Nisa Investment Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Nisa Investment Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$3K	–	2001
2018 Q3	$3K	Sell	2,000 -3,530	-64%	-$6.32K	﹤0.01%	1946
2018 Q2	$10K	Buy	5,530 +4,080	+281%	+$7.05K	﹤0.01%	1746
2018 Q1	$3K	Buy	+1,450	New	+$3.06K	﹤0.01%	1843
2017 Q3	–	Sell	-283,250	Closed	-$1.26M	–	1873
2017 Q2	$1.26M	Buy	283,250 +98,410	+53%	+$406K	0.01%	743
2017 Q1	$861K	Sell	184,840 -1,410	-0.8%	-$8.18K	0.01%	858
2016 Q4	$1.13M	Buy	186,250 +3,000	+2%	+$15.7K	0.01%	788
2016 Q3	$1.01M	Buy	183,250 +87,850	+92%	+$411K	0.01%	790
2016 Q2	$363K	Buy	+95,400	New	+$323K	﹤0.01%	1087

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCM

Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Nisa Investment Advisors's SGYP Position: Q4 2018 in Review

Nisa Investment Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 2,000 shares — an estimated $3K sold.

Nisa Investment Advisors first reported a position in SGYP in Q2 2016 and held it in 8 quarters. The position peaked at $1.26M in Q2 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Nisa Investment Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Nisa Investment Advisors sold 2,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $3K.
Nisa Investment Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 8 quarters.
Nisa Investment Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.26M in Q2 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Nisa Investment Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.